Related Experiment Video
Updated: Jan 22, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
Repurposing Quinacrine against Ebola Virus Infection In Vivo
Thomas R Lane1, Jason E Comer2,3,4, Alexander N Freiberg4,5
1Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, USA.
Abstract:
Quinacrine hydrochloride is a small-molecule, orally bioavailable drug that has been used clinically as an antimalarial and for many other applications. A machine learning model trained on Ebola virus (EBOV) screening data identified quinacrine as a potent (nanomolar) in vitro inhibitor. In the current study, quinacrine 25 mg/kg was shown to protect 70% of mice (statistically significant) from a lethal challenge with mouse-adapted EBOV with once-daily intraperitoneal dosing for 8 days.
Related Concept Videos
What are Viruses?
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Introduction to Virus
Viruses of Archaea
Viruses with RNA Genomes
Stages of Infection

